Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mortality modeling of early detection programs.

Sandra J Lee1, Marvin Zelen

  • 1Harvard School of Public Health and the Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA. lee.sandra@jimmy.harvard.edu

Biometrics
|August 30, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predicting immune-related thyroiditis using polygenic risk scores in patients with advanced melanoma.

Journal for immunotherapy of cancer·2026
Same author

Insights into inherited genetic variations and genetic ancestry of patients with high-risk melanoma.

Melanoma research·2026
Same author

Impact of immune checkpoint inhibition on ovarian reserve.

The oncologist·2026
Same author

Integrative Immune Signature of Complementary Circulating and Tumoral Biomarkers Maximizes the Predictive Power of Adjuvant Immunotherapeutic Benefits in High-risk Melanoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

Mathematical Modeling to Address Questions in Breast Cancer Screening: An Overview of the Breast Cancer Models of the Cancer Intervention and Surveillance Modeling Network.

Journal of breast imaging·2025
Same author

Academic Community Partnership in Acute Promyelocytic Leukemia and Early Mortality: The ECOG-ACRIN EA9131 Trial.

JAMA oncology·2025
Same journal

Fast penalized generalized estimating equations for large longitudinal functional datasets.

Biometrics·2026
Same journal

Causally-interpretable random-effects meta-analysis.

Biometrics·2026
Same journal

Statistical inference for mean function of partially observed functional time series.

Biometrics·2026
Same journal

Subgroup identification via Interaction Tree and Mixed Model for Repeated Measures with application to Alzheimer's disease.

Biometrics·2026
Same journal

Finite mixtures of linear quantile regressions with concomitant variables: a solution to endogeneity in longitudinal data modeling.

Biometrics·2026
Same journal

Discussion on "INTACT: a method for integration of longitudinal physical activity data from multiple sources" by Jingru Zhang, Erjia Cui, Hongzhe Li, and Haochang Shou.

Biometrics·2026
See all related articles

This study presents a probability model to predict mortality differences between early disease detection and usual care groups. The model aids in evaluating screening effectiveness and potential mortality reductions from early diagnosis.

Area of Science:

  • Biostatistics
  • Epidemiology
  • Health Services Research

Background:

  • Chronic diseases pose significant public health challenges.
  • Early detection of chronic diseases can potentially reduce mortality.
  • Comparing screening programs with usual care is crucial for healthcare policy.

Purpose of the Study:

  • To develop a general probability model for predicting cumulative mortality.
  • To compare mortality between early detection and usual care groups.
  • To evaluate the impact of screening schedules on disease-specific mortality.

Main Methods:

  • A four-state progressive disease model (disease-free, preclinical, clinical, death).
  • Incorporation of age-dependent transitions, examination sensitivity, and sojourn times.

Related Experiment Videos

  • Modeling disease stage distribution conditional on detection modality.

    • Main Results:

    • The model predicts cumulative mortality for both early detection and usual care groups.
    • It allows for comparison of mortality rates across different screening schedules.
    • The model can explore benefits for specific subpopulations.

    Conclusions:

    • The developed probability model provides a framework for evaluating early detection strategies.
    • It facilitates the assessment of mortality reductions attributable to screening and treatment advancements.
    • The model supports informed decision-making regarding public health interventions for chronic diseases.